| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.28▲ | 8.29▲ | 8.29▲ | 8.64▼ | 11.09▼ |
| MA10 | 8.28▲ | 8.29▲ | 8.26▲ | 9.15▼ | 11.66▼ |
| MA20 | 8.28▲ | 8.27▲ | 8.34▼ | 10.88▼ | 12.21▼ |
| MA50 | 8.28▲ | 8.58▼ | 8.92▼ | 11.78▼ | 34.26▼ |
| MA100 | 8.28▲ | 8.99▼ | 9.76▼ | 12.28▼ | 34.83▼ |
| MA200 | 8.38▼ | 10.10▼ | 11.68▼ | 28.87▼ | 27.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.030▲ | 0.040▲ | -0.278▼ | 1.048▲ |
| RSI | 56.480▲ | 44.979▼ | 34.156▼ | 24.787▼ | 23.993▼ |
| STOCH | 33.025 | 63.568 | 58.635 | 10.811▼ | 43.620 |
| WILL %R | -50.000 | -26.190 | -54.412 | -96.880▼ | -97.112▼ |
| CCI | 74.459 | 52.296 | 15.108 | -120.213▼ | -205.643▼ |
|
Thursday, September 24, 2026 07:46 PM
ADARx Pharmaceuticals has overshot its own IPO ambitions, as fellow RNA-focused biotech City Therapeutics also plans a public listing. | ADARx Pharmaceuticals has overshot its own IPO ambitions, as ...
|
|
Thursday, September 24, 2026 05:00 PM
ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.
|
|
Thursday, September 24, 2026 01:21 AM
Atrium's lead PRKAG2 program has received investigational new drug clearance and is moving toward the Corventis adaptive, open-label Phase I/II study. The design includes dose escalation followed by ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 8.20 | 8.365 | 8.10 | 8.29 | 221,427 |
| 24/09/26 | 8.30 | 8.49 | 8.16 | 8.19 | 355,089 |
| 23/09/26 | 9.22 | 9.31 | 8.29 | 8.33 | 433,892 |
| 22/09/26 | 9.24 | 9.485 | 9.17 | 9.22 | 241,251 |
| 21/09/26 | 8.97 | 9.34 | 8.9425 | 9.19 | 481,254 |
| 18/09/26 | 9.57 | 9.665 | 8.66 | 8.95 | 1,036,647 |
| 17/09/26 | 9.65 | 9.695 | 9.435 | 9.56 | 569,616 |
| 16/09/26 | 10.11 | 10.11 | 9.50 | 9.50 | 356,436 |
| 15/09/26 | 10.21 | 10.21 | 9.62 | 10.09 | 274,562 |
| 14/09/26 | 10.37 | 10.71 | 10.15 | 10.21 | 255,713 |
|
|
||||
|
|
||||
|
|